Related Party Transactions - Additional Information (Details) - USD ($)			1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 19, 2024	Aug. 31, 2024	Nov. 30, 2023	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Nov. 28, 2023
Related Party Transaction [Line Items]
Noncash losses for change in fair value of the Tempus Warrants				$ 0	$ 26,014,000	$ 0	$ 18,274,000
Proceeds from sale of stock						$ 17,782,000	30,079,000
Minimum | Tempus
Related Party Transaction [Line Items]
Percentage of common stock owned				10.00%		10.00%
Tempus Agreement
Related Party Transaction [Line Items]
Market development fees received						$ 6,000
Tempus Agreement | Tempus
Related Party Transaction [Line Items]
Market Development Fees			$ 6,000
Noncash losses for change in fair value of the Tempus Warrants					$ 26,000,000		$ 18,300,000
Tempus Agreement | Maximum
Related Party Transaction [Line Items]
Percentage of common stock owned				19.99%		19.99%
Percentage of its gross revenues attributable to such license						20.00%
Tempus Agreement | Minimum
Related Party Transaction [Line Items]
Percentage of its gross revenues attributable to such license						10.00%
Tempus Agreement | First Warrant | Tempus
Related Party Transaction [Line Items]
Warrants and rights outstanding									$ 18,400,000
Warrant exercise price per share									$ 2
Tempus Agreement | First Warrant | Maximum | Tempus
Related Party Transaction [Line Items]
Warrant issued to purchase stock									9,218,800
Investment Agreement | Tempus
Related Party Transaction [Line Items]
Number of shares issued		3,500,000
Share price		$ 5.07
Proceeds from sale of stock		$ 17,700,000
Investment Agreement with Merck | Merck Sharp and Dohme LLC [Member]
Related Party Transaction [Line Items]
Number of shares issued	14,044,943
Share price	$ 3.56
Proceeds from sale of stock	$ 50,000,000
Agreement reserve	10,000,000
Stock issuance cost	$ 300,000
Invoice amount				$ 1,000,000		$ 3,300,000
Receivable				$ 2,500,000		$ 2,500,000		$ 2,500,000